Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
100%
Inflammatory Mediators
100%
SerpinB3
100%
Nonalcoholic Steatohepatitis
60%
Hepatocytes
30%
Recombinant
20%
Disease Progression
20%
Macrophages
20%
Liver
10%
Reactive Oxygen Species
10%
Overexpressing
10%
Choline-deficient
10%
Chronic Liver Disease
10%
Cirrhosis
10%
Fibrosis
10%
Interleukin-1β
10%
In Vitro Experiment
10%
Phorbol Myristate Acetate
10%
Liver Damage
10%
Inflammatory Cytokines
10%
Transcript Level
10%
Macrophage Activation
10%
Methionine-choline-deficient
10%
In Vivo Experiment
10%
Galectin-3 (Gal-3)
10%
Liver Macrophages
10%
NF-κB Transcription Factor
10%
Hepatocellular Carcinoma Progression
10%
Infiltrating Macrophages
10%
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
10%
Hypoxia-inducible Factor 2
10%
THP-1 Macrophages
10%
CDAA Diet
10%
Cysteine Protease Inhibitor
10%
L-amino Acid-defined
10%
Pro-inflammatory Role
10%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Recombinant
20%
Disease Exacerbation
20%
Cytokine
20%
Choline
20%
Liver Injury
10%
Amino Acid
10%
Reactive Oxygen Metabolite
10%
Liver Cell Carcinoma
10%
Tumor Necrosis Factor
10%
Chronic Liver Disease
10%
Liver Cirrhosis
10%
Fibrosis
10%
12-O-Tetradecanoylphorbol-13-Acetate
10%
Transcription Factors
10%
Vasculotropin
10%
Proteinase Inhibitor
10%
Prothrombin
10%
Galectin 3
10%
Methionine
10%
Cysteine Proteinase
10%
Hypoxia Inducible Factor
10%
Triggering Receptor Expressed on Myeloid Cells 2
10%